Supplementary Tables S1-S9 from Identification of a CD138-Negative Therapy-Resistant Subpopulation in Multiple Myeloma with Vulnerability to Splicing Factor Inhibition

Supplementary Table S1: Patient information, Table S2: DEGs upregulated in CD138+ and CD138− MM cells detected in bulk RNA-seq, Table S3: DEGs in each cluster detected in scRNA-seq, Table S4: List of sgRNAs used in CRISPR/Cas9 screening, Table S5: List of candidate genes from CRISPR/Cas9 screening, Table S6: List of differential splicing events detected in bulk RNA-seq, Table S7: List of differential splicing events detected in scRNA-seq, Table S8: List of differential splicing events detected in RNA-seq of RBM39 KO and indisulam-treated AMO-1 cells, and Table S9: Primer sequences for amplification and sequencing of sgRNA regions, sgRNAs for CRISPR/Cas9 KO and RT-PCR primers to confirm splicing patterns.